Dr. Madhu S. Kollipara, MD, FCCP

Media Releases

Get to know Pulmonologist Dr. Madhu S. Kollipara, who serves patients in Fort Worth, Texas.

A physician specializing in pulmonary disease and internal medicine, Dr. Kollipara is affiliated with Alliance Pulmonary and Critical Care in Fort Worth, Texas.

Among his other roles, he can be found on staff at Baylor Scott & White Medical Center – College Station, Texas Health Harris Methodist Hospital Alliance, and Texas Health Harris Methodist Hospital Stephenville.

Back in 1992, Dr. Kollipara graduated with his Bachelor of Science degree in Electrical Engineering and Computer Science from the University of California at Berkeley. He earned his Bachelor of Medicine, Bachelor of Surgery degree from the Jagadguru Jayadeva Murugarajendra Medical College and completed his internship at Allegheny General Hospital/West Pennsylvania Hospital. He then went on to complete his residency in internal medicine at the St. Elizabeth Health Center, and his fellowship in pulmonary disease and critical care medicine at Louisiana State University. 

A Fellow of the American College of Chest Physicians (FCCP), he is board-certified in critical care medicine and pulmonary disease by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Pulmonology is a medical specialty that deals with diseases involving the respiratory tract. A pulmonologist is an internal medicine physician who specializes in preventing, diagnosing, and treating conditions and diseases that affect the lungs, bronchial tubes, and the respiratory system, including the nose, pharynx, and throat.

Among his most notable achievements, Dr. Kollipara has been the recipient of the Patients’ Choice Award (2013, 2012, 2011, 2009, 2008) and Compassionate Doctor Recognition (2013, 2012, 2011).

Recommended Articles

• Pulse Oximeter Use for Patients with COPD

  Pulse oximeters measure the pulse rate of an individual, which is usually marked by a small heart. This is the first number that appears while using a pulse oximeter.  It also measures the proportion of oxygenated hemoglobin in the blood within pulsating vessels. This determines the level of oxygen...

• How Depression Leads to COPD Medication Non-Adherence

  Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease that still does not have a cure. The World Health Organization predicts that COPD will become the fourth leading cause of death worldwide by 2030. The predominant cause for COPD is tobacco smoking. Most symptoms are irreversible,...

• How Is Pleurisy Diagnosed?

  Pleurisy is the inflammation of the two-layered membranes lining your lungs. Your doctor can diagnose pleurisy after taking a careful history, complete physical exam, and investigations.During the diagnosis, your doctor will exclude all the other possible causes that have a similar presentation and...

• Diagnosing Pneumonia

  Pneumonia is a serious lung infection that can be caused by bacteria, viruses, or fungi. It is a common disease, especially among the elderly and bed-ridden patients. Although it is quite serious, it can be easily treated....

• Real Benefits of Salt Therapy for Cystic Fibrosis

  Thanks to ongoing research into cystic fibrosis, physicians are now able to offer more treatment options than ever before. Many treatment options include medications and sometimes can be as intense as undergoing a lung transplant, but other methods are more conservative. Physicians have long sought...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...